Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 28% ± 4% | |
fibroblast | 3 studies | 47% ± 37% | |
ciliated cell | 3 studies | 22% ± 5% | |
basal cell | 3 studies | 47% ± 35% |
Insufficient scRNA-seq data for expression of STK19 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 849.99 | 1445 / 1445 | 100% | 5.99 | 183 / 183 |
prostate | 100% | 1022.98 | 245 / 245 | 100% | 11.34 | 501 / 502 |
pancreas | 100% | 539.59 | 327 / 328 | 100% | 10.75 | 178 / 178 |
thymus | 100% | 951.71 | 653 / 653 | 100% | 11.97 | 603 / 605 |
lung | 100% | 779.22 | 577 / 578 | 100% | 9.49 | 1153 / 1155 |
breast | 100% | 862.89 | 459 / 459 | 100% | 12.46 | 1114 / 1118 |
ovary | 100% | 1079.36 | 180 / 180 | 100% | 8.25 | 428 / 430 |
bladder | 100% | 849.52 | 21 / 21 | 99% | 10.22 | 501 / 504 |
skin | 100% | 1050.07 | 1809 / 1809 | 99% | 10.63 | 469 / 472 |
uterus | 100% | 850.84 | 170 / 170 | 99% | 12.70 | 456 / 459 |
stomach | 100% | 640.20 | 359 / 359 | 99% | 6.30 | 284 / 286 |
intestine | 100% | 790.63 | 966 / 966 | 99% | 7.23 | 522 / 527 |
brain | 99% | 595.50 | 2607 / 2642 | 100% | 12.92 | 705 / 705 |
liver | 100% | 774.87 | 226 / 226 | 99% | 7.79 | 400 / 406 |
adrenal gland | 100% | 1624.15 | 258 / 258 | 98% | 10.03 | 226 / 230 |
kidney | 100% | 966.51 | 89 / 89 | 98% | 9.46 | 880 / 901 |
adipose | 100% | 817.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 14.04 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.54 | 29 / 29 |
spleen | 100% | 972.72 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.38 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.10 | 1 / 1 |
blood vessel | 100% | 817.05 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 422.08 | 841 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 394.85 | 876 / 929 | 0% | 0 | 0 / 0 |
muscle | 92% | 251.96 | 742 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046579 | Biological process | positive regulation of Ras protein signal transduction |
GO_0006468 | Biological process | protein phosphorylation |
GO_0016607 | Cellular component | nuclear speck |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | STK19 |
Protein name | Inactive serine/threonine-protein kinase 19 (Protein G11) (Protein RP1) STK19 (Serine/threonine-protein kinase 19) Serine/threonine kinase 19 Serine/threonine kinase 19 (Serine/threonine-protein kinase 19) Serine/threonine-protein kinase 19 |
Synonyms | RP1 G11 |
Description | FUNCTION: [Isoform 1]: Inactive serine/threonine-protein kinase (Probable). May control NRAS activity via an associated kinase (Probable). .; FUNCTION: [Isoform 3]: Inactive serine/threonine-protein kinase. . |
Accessions | P49842 ENST00000425138.5 [P49842-2] ENST00000444147.5 [P49842-2] ENST00000520138.5 ENST00000375331.7 [P49842-4] ENST00000481181.5 ENST00000685781.1 [P49842-4] ENST00000433397.6 [P49842-1] A0A140T8X5 ENST00000550656.1 ENST00000519915.1 ENST00000549310.1 ENST00000674578.1 ENST00000452688.6 [P49842-1] ENST00000375333.3 [P49842-3] ENST00000547578.1 ENST00000519179.6 ENST00000431383.6 [P49842-1] B7ZLI8 ENST00000523972.5 A0A0G2JKI8 ENST00000383328.6 A0A0G2JLL1 ENST00000438256.6 [P49842-1] C9J6S8 ENST00000383327.8 A0A140TA37 ENST00000460018 ENST00000483801.6 H0YAS4 ENST00000551718.1 ENST00000426802.5 [P49842-2] ENST00000424104.5 [P49842-2] |